Learn / NKTR
NASDAQ: NKTR
Nektar Therapeutics (NKTR) stock, explained like you're 5
Nektar Therapeutics trades on the Nasdaq under the ticker NKTR. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 1.4 billion dollars.
- Ticker
- NKTR
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Small cap, about 1.4 billion dollars
Is Nektar Therapeutics a small, medium or large cap company?
No. Nektar Therapeutics is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 1.4 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Nektar Therapeutics makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves NKTR stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- NKTR Stock Soars After Nektar Reports Positive Atopic Dermatitis Trial Results (Stocktwits)
- Phase III Trial Launch Might Change The Case For Nektar Therapeutics Stock (NKTR) (Simply Wall Street)
- NKTR Mar 2027 80.000 put (NKTR270319P00080000) stock historical prices and data (Yahoo Finance UK)
- Nektar Posted Promising Alopecia Results. Here's Why It Took A 22% Beating. (Investor's Business Daily)
- Nektar Therapeutics stock rises on $90M jury verdict vs Lilly (Yahoo Finance)
Follow NKTR in your daily brief
Each trading day at 5 PM ET we post what happened to Nektar Therapeutics and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow NKTR
Questions about Nektar Therapeutics stock
What does Nektar Therapeutics do?
Nektar Therapeutics trades on the Nasdaq under the ticker NKTR. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 1.4 billion dollars.
What is the ticker symbol for Nektar Therapeutics?
Nektar Therapeutics trades under the ticker NKTR on the Nasdaq.
What is Nektar Therapeutics's market cap?
Nektar Therapeutics is a small cap stock with a market cap of about 1.4 billion dollars.
How does Nektar Therapeutics make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves NKTR stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow NKTR stock every day?
Add NKTR to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.